DatasetName,DCAF6_S(305) DCAF6_S(309) DCAF6_S(336) DCAF6_S(467) DCAF6_S(5) DCAF6_S(592) DCAF6_S(612) DCAF6_S(638) DCAF6_S(657) DCAF6_S(677) DCAF6_S(7) DCAF6_S(703) DCAF6_S(726) DCAF6_S(734) DCAF6_S(847) DCAF6_S(850) DCAF6_S(867) DCAF6_S(870) DCAF6_S(938) DCAF6_S(941) DCAF6_T(261) DCAF6_T(292) DCAF6_T(654) DCAF6_T(674) DCAF6_T(700) DCAF6_T(731),DCAF6_S(863) DCAF6_S(866)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,0.5162881170657675,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.5082064286229777,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5192636960545403,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.5135647862011972,
HS2024_6_B_T3,,
JW2015_Intensity pre1,0.5123280683637556,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5124970639957082,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5216204558711238,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.49756067679528204,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,0.5053408844461738,
RB2022_5_PreEndurance,0.5128230035859562,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5054461590923507,
WZ2023_Pu_010_30min,0.5178401088155055,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,0.515027482133701,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,
RB2022_8_RecoveryEndurance,0.5089437693960339,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5074404515917664,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,0.5074060770705573,
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,0.5057525303541802,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5169702582034327,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.5110803365758066,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.5122913300430252,
GF2025_P6_Sph,0.5112857250086663,
RB2022_2_PreSprint,0.5131653813308354,
ZX2022_CB treated Replicate 3,0.5143882081823054,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5153992606036808,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.49812923866535563,
KBE2022_Log2_Ex_34_U,0.5217307721423332,
WZ2023_Pu_005_10min,0.5161977410724176,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5166577071333827,
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,0.5135706478013977,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.5053932142693699,
EJN2021_3_Rest_Basal,0.5179353130464228,
CR2017_Ratio Replicate 1.3,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.5096055574295225,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5150843887461956,
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.517182442077038,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.5105592155534311,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,0.5146543677461319,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,0.51025215289362,
PG2020_Intensity Mock_10h_D,0.49488156911761294,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,0.5102715739226747,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5147889015159466,
RCJD2014_5min_1,0.5156575728695739,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,0.5153546080692233,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5136782136403083,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.510942793815249,
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.5077859945782637,
EJN2021_5_Rest_Basal,0.5204012441656238,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,0.5099615701511301,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,0.5189166305086208,
RB2022_1_PostEndurance,0.5160197001780497,
CR2017_Ratio Replicate 3,0.5071349206960732,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,0.4995943542022856,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5158336934846532,
HS2024_8_I_T3,,
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,0.5140425632038104,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5167717362474183,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,0.5120987086867401,
RB2022_4_RecoveryEndurance,0.5137123905930688,
RB2022_5_RecoveryEndurance,0.4896617704284406,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5200048919862192,
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,0.5111656866590807,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5084904332920137,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,0.5062719041252757,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.4991215489231797,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.505324033518352,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.5110285935017755,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.5048544878890809,
AH2018_SILAC_IT_3_X,0.5167700269604316,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,0.5122935666501744,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,0.5009537385039218,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.517341868577125,
EJN2021_4_Rest_Ins,0.5191803368955142,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.510088035138814,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,0.5054264363351818,
EJN2021_1_Rest_Ins,0.5191905052014778,
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.520494044304249,
JW2021_After_3,0.5184393429225926,
GF2025_P8_Sph,0.5087992450105439,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,
CK2022_11 200-1,0.5103989807293747,
CK2022_12 200-1,0.5095079795742766,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.5177437846060647,
AH2018_TMTMS2_2_N,0.5094489058582646,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5201332892893515,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.5080193342915312,
AH2018_TMTMS3_Pool,0.5081024191330626,
KS2014_Intensity N4,0.5129983271619467,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,0.5091829562613464,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,0.5158423994770726,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5055501865080639,
AST2020_anti-CD3+PDL2.2,0.4977826650905738,
PG2020_Intensity Mock_10h_A,0.5043349963072147,
JW2021_After_2,0.5248015054877792,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.5194091586000465,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,0.5044678450413318,
GF2025_P1_Sph,0.5064284596215707,
EJN2021_5_Ex_Basal,0.5205036889641895,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5144094804745301,
CF2017_EOC 1,0.5120847026283681,
CK2022_3 200-1,0.5102539951581435,
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,0.5043970920467543,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.5157554343672635,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,0.5071903201137752,
CK2022_2 40-1,,
RB2022_1_PostSprint,0.5050709032917133,
CK2022_4 200-1,0.5102508045327224,
JW2021_Before_2,0.514752839657764,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,0.5036210112424226,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.5196046381231129,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.5037918139304985,
CR2017_Ratio Replicate 3.2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5144183025104792,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5094968994205943,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,
CK2022_16 16-1,,
FS2019_db/db3,0.5086609194355701,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5177102137701756,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.522340233325977,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.5082209023972873,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.5201647872503711,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,0.5214115435698026,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,0.5136887794316464,
YA2020_Reporter_intensity_Normal_No.4,0.5116823173602758,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,0.5117740737775637,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5088839341085195,
GF2025_P3_Adh,0.5094782496021752,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5098181460927408,
RM2024_Intensity D0-1___2,,
LY2019_P4+,,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,0.515953843730108,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.5041413284839058,
AST2020_Control,0.49471284593381376,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.510243784128392,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.5076882647233372,
RB2022_7_RecoverySprint,0.5125445350296272,
YA2020_Reporter_intensity_Normal_No.3,0.5116701986993738,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.513714419894531,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5103331431934607,
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.5111245655423073,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.516879384631556,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,0.5081116248224771,
CR2017_Ratio Replicate 2,0.5087495273683696,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.5005514635945404,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5073449427561983,
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.5076493112248296,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,0.5110021357861824,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,0.505450387642027,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.5194482748798241,
TM2022_S2.12h.B,,
RN2012_L15,0.5093155798095176,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.519694715912548,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5128551789391388,
RB2022_1_PreSprint,0.5148266149161997,
HS2024_4_I_N1,,
CK2022_7 200-1,0.510597114343814,
CK2022_5 200-1,0.5103978293237736,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,0.5119516327461086,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5231289544612039,
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,0.5201834529237951,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.5184077108578335,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,0.5248663143563793,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,0.5172992673044392,
AH2018_SILAC_IT_1_X,0.5166866928415993,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,0.5051518287350364,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.524290889126684,
WZ2023_Pe_025_20min,0.5148500047587906,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.5088043681712455,
RN2012_H06,0.506285759533991,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.5176401828821052,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,0.5074631927413171,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5082288113664167,
WZ2023_Su_025_10min,0.5182993193346174,
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,0.5106011736175641,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5189764867314904,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,0.5124076378152957,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5175219079073768,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,0.4992535802030975,
KS2014_Intensity,,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,0.5120864157632612,
RN2012_L10,,
PG2020_Intensity 4h_C,,
EP2017_Mitotic R#3 normalized log2 ratio,0.5136096300261049,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5161649351250183,
RB2022_8_PostStrength,0.513543358019277,
AH2018_SILAC_IT_2_X,0.5167283349283965,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.5093542939035687,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5173818019222585,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5090129376802733,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5153472049360566,
GF2025_P9_Sph,0.5082028961022181,
CK2022_6 200-1,0.510320431441913,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5080596077591703,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,0.5127623061981386,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,0.5110664983865834,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5103521612476107,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5095428688807272,
RB2022_7_PostEndurance,0.5125649415773815,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.521461251561657,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.5202995203002727,
FR2021_Intensity.M,,
RB2022_2_PostSprint,0.5103975164918405,
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.508807598805351,
EP2017_Untreated R#3 log2 ratio,0.5109958441468089,
RB2022_2_PostStrength,0.5144723352334228,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5160798540918557,
HS2024_8_PD_T2,,
FS2019_Ctr2,0.5069152427517984,
RB2022_6_PreEndurance,0.5109927711751092,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.5093800588369949,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,0.48878333036646104,
CR2017_Ratio Replicate 2.3,0.5078104306397339,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5206848874535048,
YA2020_Reporter_intensity_Normal_No.2,0.5093027303056888,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.5111792810298939,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,
RAM2015_Log2 B,0.5136672481131669,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.5200215353166827,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,0.5059639956900785,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,0.5086186097692532,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.5085667590753754,
WZ2023_Su_025_30min,0.5172988811851301,
AH2018_LFQ_4_N,,
CR2017_Ratio Replicate 1.2,,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,0.5103238071916041,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,0.5205551105195024,
RB2022_7_PreEndurance,0.5075469161497776,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,0.51411694937671,
LY2019_P6+,,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.507166425216196,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,0.5084509512653823,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5088150190270873,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,0.5105492445967881,
KS2014_Intensity C5,,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,0.5004922654132442,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5148585673058436,
RB2022_3_PostStrength,0.5160992047693396,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,0.5025305305705265,
KS2014_Intensity E15_3,,
GF2025_P3_Sph,0.5100097451216898,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.519263048904778,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.5110391678156502,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5173044359134141,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.5144236682463839,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,
ZQ2022_N1,,
LY2019_P6-,,
RM2024_Intensity D2-3,,
UK2020_HCM_1,0.5060173435961979,
JW2015_Intensity pre2,0.5141204051900313,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5102809526371266,
AH2018_LFQ_3_N,,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.54828067162704,
UK2020_UA_1,0.5056307414406416,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,0.5099121755855491,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.516841858856539,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,0.5109069664813207,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.5188247323522314,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.5208274723058118,
EP2017_Pervanadate R#3 log2 ratio,0.5168091810093555,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.5158679369898624,
RB2022_6_PostStrength,0.5095276643288889,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,0.5141175268373154,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.509410915410359,
LY2019_P3-,,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.5187812279539467,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5157398370576423,
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.5188678767634333,
AST2020_Control.1,0.4986120357760878,
JW2015_Intensity cap1,0.5142706114402709,
PG2020_Intensity CT_A,,
FS2019_Ctr3,0.5053496399078157,
WZ2023_Pu_025_20min,0.5180892051130315,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5218794570719194,
RB2022_1_RecoveryStrength,0.5142240099199156,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5090044306244336,
RB2022_4_PreSprint,0.5130033958955109,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5075525549760496,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,0.5012781108271613,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5200349983463746,
LY2019_P8+,,
RB2022_2_RecoveryEndurance,0.5097847951841495,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,0.4979383596047203,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.508061947135909,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.508668764706255,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5073882310869972,
LY2019_P2-,,
AH2018_LFQ_IT_1_X,0.5203511006383811,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,0.5083514800309566,
WZ2023_Pe_005_20min,0.5143229578808559,
AST2020_Control.2,0.4972388275468287,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.5114374030355509,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,0.5071459986017746,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.512431643840248,
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5167501197270663,
KS2014_Intensity C2,0.5117284711559618,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.508852981319172,
CK2022_9 200-1,0.5098240604946591,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5101373881356644,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,0.5189374232506275,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.5082910406181733,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5120039852134739,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5169936575130305,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.5130246566613403,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5116740117798666,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,0.5117193098039349,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.49788510385107887,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,0.5075783592965204,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.49432936599009675,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5172713999331109,
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,0.5095495414615722,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.5200041208595553,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5100800654601869,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5177072004578467,
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.5190803319207,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5176528845597177,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.5108663480337543,
KBE2022_Log2_Ex_44_U,0.5194031278197694,
WZ2023_Pe_010_20min,0.5167585558380158,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.5205915141078821,
RB2022_3_PreStrength,0.5139250555104915,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.5022749832995703,
KS2014_Intensity C1,0.5116540818127981,
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,
AH2018_SILAC_M_2_X,,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5096322697061285,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5175468563618009,
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.50856688461493,
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.5217631486246959,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.5130551665520224,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.5227694045448273,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,0.5060046564603439,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5135349403822945,
EJN2021_2_Ex_Basal,0.5203141060791248,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,0.5093937693079348,
CF2017_EOC 2,0.5093797235959099,
RB2022_6_PostEndurance,0.5114171730918452,
AH2018_SILAC_1_N,0.5200106042637853,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,0.5056944484467221,
RB2022_7_PreSprint,0.5139227527821149,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,0.5136141237931731,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,0.5146317774025859,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5089905090423522,
AR2021_L41 1 μM,0.5190627265510318,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.510800127140249,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.5128584776439455,
KS2014_Intensity C4,0.5127769480521228,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.5124949256868923,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.509635793797634,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,0.5125970157859494,
AH2018_SILAC_IT_3_C,0.5205866430566952,
WZ2023_Pu_025_10min,0.5151650865781888,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.5180810892144262,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.5101779727200862,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.5165106646679992,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.5138747397794904,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.5209899551481698,
CK2022_5 40-1,,
AH2018_LFQ_3_X,,
UK2020_UA_3,0.5057811491495248,
LY2019_P7-,,
GF2025_P5_Adh,0.5256123271139564,
RB2022_1_PostStrength,0.5294674882672937,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.508285441683129,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5049951580663736,
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,0.5158781841464459,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.5119780498964452,
AH2018_LFQ_3_C,,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,
YA2020_Reporter_intensity_Cancer_No.4,0.5103942286012203,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.506963380225518,
RB2022_2_PreEndurance,0.5139621632176878,
JW2021_Before_1,0.5156038403039379,
KBE2022_Log2_Ex_25_T,0.5183241172972164,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,0.4996512309318359,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,0.5132248885195663,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5130795804257272,
AH2018_TMTMS2_1_X,0.5117337803330144,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.5205008847212015,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.5125651499257866,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.5203703651517114,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.5073267636302868,
CF2017_FTE 14,0.5080304870160532,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.5169936944540088,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5213781055510127,
AS2011_Ratio H/L Normalized RNAi_2_1,,
